Concepts (278)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Failure | 33 | 2024 | 2330 | 4.360 |
Why?
|
Heart Transplantation | 23 | 2023 | 904 | 1.860 |
Why?
|
Heart-Assist Devices | 20 | 2023 | 1047 | 1.680 |
Why?
|
Heart Failure, Systolic | 2 | 2021 | 34 | 1.380 |
Why?
|
Diuretics | 4 | 2022 | 170 | 1.090 |
Why?
|
Water-Electrolyte Imbalance | 3 | 2023 | 98 | 1.070 |
Why?
|
Cardiomyopathies | 8 | 2023 | 548 | 0.970 |
Why?
|
Sodium Potassium Chloride Symporter Inhibitors | 3 | 2022 | 31 | 0.940 |
Why?
|
Anemia, Iron-Deficiency | 3 | 2021 | 139 | 0.920 |
Why?
|
Hospitalization | 7 | 2024 | 2170 | 0.900 |
Why?
|
Child | 57 | 2024 | 30560 | 0.880 |
Why?
|
Shock, Cardiogenic | 3 | 2024 | 193 | 0.860 |
Why?
|
Heart Defects, Congenital | 7 | 2023 | 1796 | 0.850 |
Why?
|
Renal Insufficiency | 3 | 2018 | 304 | 0.810 |
Why?
|
Hyponatremia | 2 | 2023 | 86 | 0.690 |
Why?
|
Central Venous Pressure | 1 | 2018 | 26 | 0.630 |
Why?
|
Creatinine | 2 | 2018 | 525 | 0.600 |
Why?
|
Infant | 27 | 2023 | 13994 | 0.580 |
Why?
|
Extracorporeal Membrane Oxygenation | 6 | 2019 | 640 | 0.580 |
Why?
|
Hospital Mortality | 7 | 2024 | 1233 | 0.570 |
Why?
|
Cardiotonic Agents | 4 | 2019 | 153 | 0.560 |
Why?
|
Child, Preschool | 30 | 2023 | 17072 | 0.560 |
Why?
|
Glomerular Filtration Rate | 3 | 2021 | 588 | 0.560 |
Why?
|
Natriuretic Peptide, Brain | 4 | 2019 | 327 | 0.500 |
Why?
|
Ventricular Dysfunction, Left | 3 | 2014 | 402 | 0.480 |
Why?
|
Retrospective Studies | 39 | 2024 | 39959 | 0.480 |
Why?
|
Cardiovascular Agents | 2 | 2020 | 104 | 0.470 |
Why?
|
Hospitals, Pediatric | 7 | 2018 | 796 | 0.470 |
Why?
|
Mortality | 1 | 2016 | 347 | 0.460 |
Why?
|
Anemia | 2 | 2018 | 725 | 0.450 |
Why?
|
Adolescent | 33 | 2023 | 32689 | 0.420 |
Why?
|
Acute Kidney Injury | 5 | 2023 | 758 | 0.390 |
Why?
|
Death, Sudden, Cardiac | 3 | 2014 | 247 | 0.380 |
Why?
|
Graft Rejection | 10 | 2023 | 844 | 0.350 |
Why?
|
Humans | 68 | 2024 | 270713 | 0.340 |
Why?
|
Male | 47 | 2023 | 128479 | 0.330 |
Why?
|
Cardiology | 1 | 2014 | 512 | 0.310 |
Why?
|
Infant, Newborn | 13 | 2021 | 8603 | 0.300 |
Why?
|
Female | 45 | 2023 | 148885 | 0.300 |
Why?
|
Sinoatrial Node | 1 | 2007 | 24 | 0.290 |
Why?
|
Heart Arrest | 2 | 2014 | 381 | 0.290 |
Why?
|
Acute Disease | 5 | 2023 | 2492 | 0.280 |
Why?
|
Cohort Studies | 12 | 2021 | 9463 | 0.280 |
Why?
|
Practice Patterns, Physicians' | 2 | 2020 | 1301 | 0.280 |
Why?
|
Risk Factors | 12 | 2024 | 17861 | 0.270 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2020 | 242 | 0.260 |
Why?
|
Registries | 5 | 2021 | 2210 | 0.260 |
Why?
|
Milrinone | 1 | 2006 | 31 | 0.260 |
Why?
|
Infusions, Parenteral | 1 | 2006 | 191 | 0.260 |
Why?
|
Pediatrics | 2 | 2019 | 1195 | 0.260 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2020 | 316 | 0.250 |
Why?
|
Renal Insufficiency, Chronic | 3 | 2023 | 713 | 0.250 |
Why?
|
Tertiary Care Centers | 2 | 2019 | 419 | 0.250 |
Why?
|
Pacemaker, Artificial | 1 | 2007 | 209 | 0.240 |
Why?
|
Treatment Outcome | 20 | 2023 | 33847 | 0.230 |
Why?
|
Sodium | 2 | 2023 | 336 | 0.230 |
Why?
|
Coronary Stenosis | 1 | 2005 | 87 | 0.230 |
Why?
|
Dopamine | 1 | 2006 | 334 | 0.230 |
Why?
|
Arginine Vasopressin | 1 | 2004 | 66 | 0.230 |
Why?
|
Time Factors | 9 | 2020 | 12978 | 0.230 |
Why?
|
Emergency Service, Hospital | 2 | 2009 | 1257 | 0.230 |
Why?
|
Patient Readmission | 2 | 2020 | 571 | 0.220 |
Why?
|
Incidence | 6 | 2018 | 5825 | 0.220 |
Why?
|
Heart Rate | 2 | 2023 | 744 | 0.210 |
Why?
|
Young Adult | 10 | 2023 | 22243 | 0.210 |
Why?
|
Length of Stay | 4 | 2019 | 1997 | 0.210 |
Why?
|
Kidney Diseases | 1 | 2008 | 679 | 0.210 |
Why?
|
Developmental Disabilities | 1 | 2007 | 695 | 0.210 |
Why?
|
Hypernatremia | 1 | 2023 | 29 | 0.210 |
Why?
|
Myocarditis | 3 | 2015 | 177 | 0.200 |
Why?
|
Chlorides | 1 | 2022 | 137 | 0.200 |
Why?
|
Flecainide | 1 | 2002 | 29 | 0.200 |
Why?
|
Sotalol | 1 | 2002 | 34 | 0.200 |
Why?
|
Transferrin | 1 | 2021 | 73 | 0.200 |
Why?
|
Risk Assessment | 5 | 2020 | 6766 | 0.190 |
Why?
|
Hypotension | 2 | 2022 | 225 | 0.190 |
Why?
|
Ambulatory Care | 1 | 2006 | 592 | 0.190 |
Why?
|
Critical Illness | 3 | 2023 | 734 | 0.190 |
Why?
|
Mineralocorticoid Receptor Antagonists | 1 | 2020 | 28 | 0.180 |
Why?
|
Tachycardia, Supraventricular | 1 | 2002 | 106 | 0.180 |
Why?
|
Prognosis | 8 | 2023 | 22528 | 0.180 |
Why?
|
Severity of Illness Index | 5 | 2016 | 4394 | 0.180 |
Why?
|
Syndrome | 3 | 2009 | 1409 | 0.170 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2002 | 235 | 0.170 |
Why?
|
Thrombosis | 2 | 2022 | 742 | 0.170 |
Why?
|
Texas | 6 | 2016 | 6446 | 0.170 |
Why?
|
Databases, Factual | 3 | 2016 | 2258 | 0.170 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2020 | 143 | 0.170 |
Why?
|
North America | 1 | 2020 | 337 | 0.160 |
Why?
|
Patient Admission | 2 | 2014 | 231 | 0.160 |
Why?
|
Adult | 12 | 2024 | 82041 | 0.160 |
Why?
|
Aorta, Thoracic | 1 | 2023 | 532 | 0.150 |
Why?
|
Unnecessary Procedures | 1 | 2019 | 101 | 0.150 |
Why?
|
Iron | 1 | 2021 | 380 | 0.150 |
Why?
|
Overweight | 1 | 2021 | 484 | 0.150 |
Why?
|
Cardiac Surgical Procedures | 3 | 2016 | 1149 | 0.150 |
Why?
|
Age of Onset | 1 | 2020 | 853 | 0.150 |
Why?
|
Tracheostomy | 1 | 2020 | 253 | 0.150 |
Why?
|
Comorbidity | 3 | 2020 | 2393 | 0.150 |
Why?
|
Multivariate Analysis | 5 | 2019 | 4317 | 0.140 |
Why?
|
American Heart Association | 1 | 2019 | 287 | 0.140 |
Why?
|
Walking | 1 | 2019 | 270 | 0.140 |
Why?
|
Heart Ventricles | 2 | 2019 | 837 | 0.140 |
Why?
|
Echocardiography | 2 | 2018 | 1219 | 0.130 |
Why?
|
Cardio-Renal Syndrome | 1 | 2016 | 6 | 0.130 |
Why?
|
Medical Records | 2 | 2016 | 441 | 0.130 |
Why?
|
United States | 7 | 2021 | 15828 | 0.130 |
Why?
|
Age Factors | 5 | 2020 | 5441 | 0.130 |
Why?
|
Cardiomyopathy, Hypertrophic | 2 | 2009 | 166 | 0.130 |
Why?
|
Hypertrophy | 1 | 2016 | 161 | 0.130 |
Why?
|
Kidney Transplantation | 1 | 2021 | 750 | 0.130 |
Why?
|
Postoperative Complications | 6 | 2016 | 5674 | 0.130 |
Why?
|
Hospital Charges | 1 | 2015 | 86 | 0.120 |
Why?
|
Ventricular Dysfunction | 1 | 2015 | 33 | 0.120 |
Why?
|
Drug Utilization Review | 1 | 2014 | 37 | 0.120 |
Why?
|
Cardiac Catheterization | 3 | 2023 | 675 | 0.120 |
Why?
|
Hemoglobins | 1 | 2016 | 480 | 0.110 |
Why?
|
Pharmacy Service, Hospital | 1 | 2014 | 58 | 0.110 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2014 | 58 | 0.110 |
Why?
|
Isolated Noncompaction of the Ventricular Myocardium | 1 | 2014 | 43 | 0.110 |
Why?
|
Patient Discharge | 2 | 2020 | 699 | 0.110 |
Why?
|
Kidney Failure, Chronic | 1 | 2021 | 931 | 0.110 |
Why?
|
Cardiovascular Diseases | 1 | 2006 | 2219 | 0.110 |
Why?
|
Stroke Volume | 2 | 2006 | 550 | 0.100 |
Why?
|
Tachycardia, Ventricular | 1 | 2015 | 200 | 0.100 |
Why?
|
Heart | 1 | 2019 | 1173 | 0.100 |
Why?
|
Cardiomyopathy, Dilated | 3 | 2019 | 239 | 0.100 |
Why?
|
Liver Transplantation | 1 | 2021 | 1188 | 0.100 |
Why?
|
Graft Survival | 4 | 2021 | 1076 | 0.100 |
Why?
|
Prevalence | 2 | 2018 | 3395 | 0.100 |
Why?
|
Electronic Health Records | 1 | 2019 | 854 | 0.100 |
Why?
|
Drug Prescriptions | 1 | 2014 | 309 | 0.100 |
Why?
|
Pseudomonas Infections | 1 | 2013 | 165 | 0.100 |
Why?
|
Odds Ratio | 1 | 2016 | 2299 | 0.090 |
Why?
|
Electrocardiography | 2 | 2007 | 1146 | 0.090 |
Why?
|
Candidiasis | 1 | 2013 | 278 | 0.090 |
Why?
|
Health Care Costs | 1 | 2015 | 696 | 0.090 |
Why?
|
Biomarkers | 2 | 2016 | 5048 | 0.090 |
Why?
|
Chronic Disease | 1 | 2016 | 1824 | 0.090 |
Why?
|
Colloids | 1 | 2009 | 35 | 0.090 |
Why?
|
Isotonic Solutions | 1 | 2009 | 43 | 0.090 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2014 | 347 | 0.080 |
Why?
|
Natriuretic Agents | 1 | 2009 | 32 | 0.080 |
Why?
|
Disease Progression | 3 | 2016 | 6881 | 0.080 |
Why?
|
Blood Chemical Analysis | 1 | 2009 | 112 | 0.080 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 2395 | 0.080 |
Why?
|
Ventricular Function, Left | 2 | 2022 | 563 | 0.080 |
Why?
|
Kidney | 2 | 2023 | 2102 | 0.080 |
Why?
|
Hemodynamics | 2 | 2022 | 941 | 0.070 |
Why?
|
Kidney Function Tests | 1 | 2008 | 198 | 0.070 |
Why?
|
Virus Diseases | 1 | 2011 | 375 | 0.070 |
Why?
|
Consanguinity | 1 | 2007 | 116 | 0.070 |
Why?
|
Staphylococcal Infections | 1 | 2013 | 682 | 0.070 |
Why?
|
Body Mass Index | 2 | 2021 | 2227 | 0.070 |
Why?
|
Transplantation Immunology | 1 | 2007 | 107 | 0.070 |
Why?
|
Electromyography | 1 | 2007 | 232 | 0.070 |
Why?
|
Predictive Value of Tests | 4 | 2008 | 4966 | 0.070 |
Why?
|
Ticlopidine | 1 | 2006 | 49 | 0.070 |
Why?
|
Systole | 1 | 2006 | 217 | 0.070 |
Why?
|
Glycogen Storage Disease Type IIb | 1 | 2005 | 5 | 0.070 |
Why?
|
Cachexia | 1 | 2007 | 154 | 0.060 |
Why?
|
Wolff-Parkinson-White Syndrome | 2 | 2005 | 74 | 0.060 |
Why?
|
Leukopenia | 1 | 2005 | 152 | 0.060 |
Why?
|
Tachycardia | 1 | 2005 | 84 | 0.060 |
Why?
|
Hyperglycemia | 1 | 2008 | 335 | 0.060 |
Why?
|
Myocardium | 2 | 2008 | 1180 | 0.060 |
Why?
|
Cardiac Output, Low | 1 | 2005 | 72 | 0.060 |
Why?
|
Prospective Studies | 1 | 2020 | 13419 | 0.060 |
Why?
|
Codon, Nonsense | 1 | 2005 | 159 | 0.060 |
Why?
|
Intraoperative Complications | 1 | 2007 | 287 | 0.060 |
Why?
|
Reference Values | 1 | 2006 | 1127 | 0.060 |
Why?
|
Fibrinolytic Agents | 1 | 2006 | 293 | 0.060 |
Why?
|
Aortic Coarctation | 1 | 2005 | 105 | 0.060 |
Why?
|
Cause of Death | 1 | 2007 | 781 | 0.060 |
Why?
|
Leukocytes | 1 | 2005 | 420 | 0.060 |
Why?
|
Pulmonary Circulation | 1 | 2004 | 132 | 0.050 |
Why?
|
Outpatients | 1 | 2006 | 463 | 0.050 |
Why?
|
Autonomic Nervous System | 1 | 2023 | 73 | 0.050 |
Why?
|
Patient Selection | 2 | 2010 | 2029 | 0.050 |
Why?
|
Probability | 2 | 2019 | 886 | 0.050 |
Why?
|
Resuscitation | 1 | 2005 | 268 | 0.050 |
Why?
|
Dilatation | 1 | 2023 | 86 | 0.050 |
Why?
|
Infant, Low Birth Weight | 1 | 2003 | 144 | 0.050 |
Why?
|
Abdominal Pain | 1 | 2005 | 377 | 0.050 |
Why?
|
Hirudins | 1 | 2022 | 41 | 0.050 |
Why?
|
Infant Welfare | 1 | 2002 | 28 | 0.050 |
Why?
|
Obesity | 2 | 2021 | 2895 | 0.050 |
Why?
|
Case-Control Studies | 2 | 2019 | 6233 | 0.050 |
Why?
|
Antithrombins | 1 | 2022 | 62 | 0.050 |
Why?
|
Renal Dialysis | 2 | 2021 | 903 | 0.050 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2002 | 70 | 0.050 |
Why?
|
Thinness | 1 | 2021 | 78 | 0.050 |
Why?
|
Hemolysis | 1 | 2021 | 125 | 0.050 |
Why?
|
Coronary Vessels | 1 | 2005 | 606 | 0.050 |
Why?
|
Catheter Ablation | 1 | 2005 | 574 | 0.040 |
Why?
|
Mitochondrial Proteins | 1 | 2023 | 377 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 3 | 2021 | 6257 | 0.040 |
Why?
|
Follow-Up Studies | 4 | 2018 | 15275 | 0.040 |
Why?
|
Biopsy | 2 | 2023 | 3490 | 0.040 |
Why?
|
Heparin | 1 | 2022 | 343 | 0.040 |
Why?
|
Resource Allocation | 1 | 2019 | 60 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2022 | 14638 | 0.040 |
Why?
|
Immunosuppressive Agents | 1 | 2005 | 1436 | 0.040 |
Why?
|
Benchmarking | 1 | 2020 | 276 | 0.040 |
Why?
|
Bilirubin | 1 | 2019 | 226 | 0.040 |
Why?
|
Hemorrhage | 1 | 2022 | 724 | 0.040 |
Why?
|
Arrhythmias, Cardiac | 2 | 2015 | 501 | 0.040 |
Why?
|
Public Health | 1 | 2019 | 280 | 0.040 |
Why?
|
Survival Rate | 2 | 2021 | 12530 | 0.030 |
Why?
|
Transplant Recipients | 1 | 2019 | 335 | 0.030 |
Why?
|
Recombinant Proteins | 1 | 2022 | 2986 | 0.030 |
Why?
|
Peptide Fragments | 1 | 2022 | 1310 | 0.030 |
Why?
|
Anticoagulants | 1 | 2022 | 777 | 0.030 |
Why?
|
Drug Therapy, Combination | 1 | 2002 | 2343 | 0.030 |
Why?
|
Respiration, Artificial | 1 | 2019 | 585 | 0.030 |
Why?
|
Coronary Care Units | 1 | 2016 | 38 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2019 | 5099 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2019 | 657 | 0.030 |
Why?
|
Risk | 1 | 2019 | 1930 | 0.030 |
Why?
|
Oxygen | 1 | 2019 | 786 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2016 | 315 | 0.030 |
Why?
|
Logistic Models | 1 | 2021 | 3429 | 0.030 |
Why?
|
Quality of Life | 2 | 2020 | 4810 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2002 | 5056 | 0.030 |
Why?
|
Cardiopulmonary Bypass | 1 | 2016 | 384 | 0.030 |
Why?
|
Pseudomonas | 1 | 2013 | 22 | 0.030 |
Why?
|
Recurrence | 1 | 2002 | 4878 | 0.030 |
Why?
|
Infant Mortality | 1 | 2014 | 143 | 0.030 |
Why?
|
Staphylococcus | 1 | 2013 | 98 | 0.030 |
Why?
|
Linear Models | 1 | 2015 | 1093 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2002 | 4838 | 0.030 |
Why?
|
Respiratory Insufficiency | 1 | 2015 | 343 | 0.030 |
Why?
|
Membrane Proteins | 1 | 2023 | 2922 | 0.030 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2016 | 476 | 0.020 |
Why?
|
Heart Diseases | 2 | 2008 | 722 | 0.020 |
Why?
|
Candida | 1 | 2013 | 171 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2015 | 966 | 0.020 |
Why?
|
Phenotype | 1 | 2023 | 6502 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2021 | 3841 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2007 | 7916 | 0.020 |
Why?
|
Genetic Testing | 1 | 2019 | 1692 | 0.020 |
Why?
|
Contraindications | 1 | 2010 | 153 | 0.020 |
Why?
|
Regression Analysis | 1 | 2013 | 1562 | 0.020 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2009 | 112 | 0.020 |
Why?
|
Isoantibodies | 1 | 2008 | 121 | 0.020 |
Why?
|
Immunoassay | 1 | 2008 | 212 | 0.020 |
Why?
|
Assisted Circulation | 1 | 2007 | 36 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2010 | 655 | 0.020 |
Why?
|
Forecasting | 1 | 2010 | 699 | 0.020 |
Why?
|
Stroke | 1 | 2015 | 1061 | 0.020 |
Why?
|
Survival Analysis | 2 | 2009 | 9281 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2008 | 580 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 2007 | 449 | 0.020 |
Why?
|
Defibrillators, Implantable | 1 | 2009 | 227 | 0.020 |
Why?
|
Hypoglycemia | 1 | 2008 | 221 | 0.020 |
Why?
|
Postoperative Period | 1 | 2008 | 666 | 0.020 |
Why?
|
Lysosomal-Associated Membrane Protein 2 | 1 | 2005 | 12 | 0.020 |
Why?
|
Papillary Muscles | 1 | 2005 | 21 | 0.020 |
Why?
|
Equipment Failure | 1 | 2006 | 192 | 0.020 |
Why?
|
Warfarin | 1 | 2006 | 145 | 0.020 |
Why?
|
Muscular Diseases | 1 | 2005 | 157 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2007 | 982 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2008 | 1381 | 0.010 |
Why?
|
Antigens, CD | 1 | 2008 | 1420 | 0.010 |
Why?
|
Aspirin | 1 | 2006 | 373 | 0.010 |
Why?
|
Blood Glucose | 1 | 2008 | 1254 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 2005 | 1117 | 0.010 |
Why?
|
Gene Frequency | 1 | 2005 | 1246 | 0.010 |
Why?
|
Morbidity | 1 | 2003 | 397 | 0.010 |
Why?
|
Exercise | 1 | 2009 | 1221 | 0.010 |
Why?
|
Seizures | 1 | 2007 | 996 | 0.010 |
Why?
|
Mass Screening | 1 | 2008 | 1547 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2008 | 5157 | 0.010 |
Why?
|
Mental Disorders | 1 | 2007 | 878 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2005 | 1175 | 0.010 |
Why?
|
Algorithms | 1 | 2009 | 3906 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2005 | 7232 | 0.010 |
Why?
|
Middle Aged | 1 | 2007 | 90533 | 0.000 |
Why?
|